Last Thursday (12 Sep 2019), we had a wonderful event at CRC Auditorium, MD 11 NUS -- Mass Spectrometry Imaging Symposium 2019 -- which aim is to showcase the state of the art of mass spectrometry imaging in the clinical arena.

It was a great honor to have the world leading scientists and translational clinicians here in Singapore for the Mass Spectrometry Imaging Symposium and the Inauguration of Bruker-NUH-NUS Collaboration. 

Thanks to Dr Glenn Bonney and his team, the SurgiCAL ProtEomics Laboratory (SCALPEL) at NUS, for hosting the series of fulfilling conference and meetings. And thanks to all the international faculties and NUS invited faculties for sharing their wealth of expertise in mass spectrometry imaging.

There were tremendous learning opportunities from Prof Ron Heeren (Distinguished Professor, Limburg Chair, Maastricht University, Netherlands), Prof Richard Drake (Director, Medical University South Carolina Proteomics Centre, USA), Dr Kristina Schwamborn (Consultant Pathologist, TU Munich, Germany), Dr Gaelin Looi Wen Donq (Applications Scientist, Bruker Daltonics, NUS Singapore), Dr Alice Ly (Research & Development Manager, Bruker Daltonics, Germany), A/Professor Nathalie Agar (Director, Surgical Molecular Imaging Laboratory, Brigham and Women‘s Hospital, USA), A/Professor Ganesh Srinivasan Anand (Director, SingMass and Protein & Proteomics Centre, National University of Singapore), and Dr Glenn Bonney (Consultant Hepatobiliary and Transplant Surgeon, National University Hospital Singapore) during their presentation.

The Mass Spectrometry Imaging Symposium 2019 was well attended by over 160 delegates from Singapore, Malaysia, India and South Korea. Thank you all for coming! And thanks to the support from the admin staff at the Department of Surgery, NUS and iHealthtech for making this event successful!

Here is the program highlight of what were covered during the symposium:

TimeTitle
9.00am Participant registration

10:00am

Two decades in evolution of translational proteomics: the history, development and application of mass spectrometry imaging
Professor Ron Heeren
Distinguished Professor, Limburg chair, Maastricht University, Netherlands

10:45am

Interrogation of N-glycans as novel cancer biomarkers by MALDI imaging 
Professor Richard Drake
Director, Medical University South Carolina Proteomics Centre, USA

11:15am

The future is molecular pathology: MALDI imaging in histological analysis
Dr Kristina Schwamborn
Consultant Pathologist, TU Munich, Germany
11:45am Lunch

01:00pm

Solutions for mass spectrometry imaging 
Dr Gaelin Looi Wen Donq
Applications Scientist, Bruker Daltonics, NUS Singapore

01:45pm

Current applications of MALDI imaging world wide 
Dr Gaelin Looi Wen Donq
Applications Scientist, Bruker Daltonics, NUS Singapore

02:30pm

Achieving reproducibility of MALDI imaging in the clinical setting 
Dr Alice Ly
R&D manager, Bruker Daltonics, Germany
03:15pm Coffee Break

03:30pm

Integrating radiological imaging with mass spectrometry imaging
A/Professor Nathalie Agar
Director of Surgical Molecular Imaging Laboratory, Brigham and Women‘s Hospital, USA

04:00pm 

SingMass: A nucleus for mass spectrometry partnership in Singapore 
A/Professor Ganesh Srinivasan Anand
Director, SingMass and Protein & Proteomics Centre, National University of Singapore

04:10pm

Translating proteomics in a clinical arena: from benchside to bladeside 
Dr Glenn Kunnath Bonney
Consultant Hepatobiliary and Transplant Surgeon, National University Hospital Singapore
04:30pm Inauguration of Bruker-NUH-NUS collaboration
End

04:45pm

Tour of SurgiCAL ProtEomics Laboratory (SCALPEL) and iHealthtech (NUS) 
For invited guests only

Visit our LinkedIn page for more photos! 

https://www.linkedin.com/feed/update/urn:li:activity:6578467077164752896

About Mass Spectrometry Imaging:

Mass spectrometry imaging allows tissue to be directly probed at the molecular level while maintaining microscopic spatial distribution, good resolution and excellent reproducibility. This relatively new technology has already made a significant impact in translational science and with new protocols and solutions in the pipeline, it promises to continue to do so for years to come.

To find out more: https://www.bruker.com/applications/life-sciences/maldi-imaging.html